Insider Buy/Sell Ratio — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Technology
Buys568
Sells11225
Buy $$3.78B
Sell $$12.21B
Ratio1:3.23
% Change vs. Prior
Ratio -82.9%Value -58.7%
Healthcare
Buys581
Sells4995
Buy $$342.15M
Sell $$8.91B
Ratio1:26.05
% Change vs. Prior
Ratio +12.2%Value -51.5%
Consumer Cyclical
Buys244
Sells2016
Buy $$93.12M
Sell $$7.72B
Ratio1:82.91
% Change vs. Prior
Ratio -97.3%Value +75.6%
Financial Services
Buys1046
Sells3031
Buy $$617.30M
Sell $$3.83B
Ratio1:6.20
% Change vs. Prior
Ratio -7.6%Value -2.9%
Energy
Buys243
Sells522
Buy $$98.79M
Sell $$4.34B
Ratio1:43.91
% Change vs. Prior
Ratio -4.8%Value -23.2%
Industrials
Buys458
Sells2119
Buy $$810.01M
Sell $$2.61B
Ratio1:3.22
% Change vs. Prior
Ratio +639.3%Value -57.5%
Consumer Defensive
Buys140
Sells675
Buy $$70.15M
Sell $$2.65B
Ratio1:37.82
% Change vs. Prior
Ratio -65.6%Value +41.8%
Communication Services
Buys136
Sells945
Buy $$77.22M
Sell $$882.74M
Ratio1:11.43
% Change vs. Prior
Ratio -13.2%Value -45.4%
Basic Materials
Buys165
Sells220
Buy $$21.37M
Sell $$437.94M
Ratio1:20.50
% Change vs. Prior
Ratio -58.7%Value -58.0%
Real Estate
Buys236
Sells307
Buy $$40.82M
Sell $$181.60M
Ratio1:4.45
% Change vs. Prior
Ratio -36.9%Value -40.7%
Utilities
Buys56
Sells160
Buy $$27.46M
Sell $$96.28M
Ratio1:3.51
% Change vs. Prior
Ratio +2616.4%Value -98.2%
By Industry
Hardware, Equipment & Parts
Buys26
Sells1126
Buy $$3.54B
Sell $$692.25M
Ratio5.11:1
% Change vs. Prior
Ratio -86.4%Value -83.1%
Biotechnology
Buys362
Sells3016
Buy $$295.63M
Sell $$3.77B
Ratio1:12.74
% Change vs. Prior
Ratio -59.0%Value +76.5%
Software - Infrastructure
Buys57
Sells3466
Buy $$21.38M
Sell $$2.69B
Ratio1:125.97
% Change vs. Prior
Ratio -19.1%Value -46.5%
Software - Application
Buys308
Sells2304
Buy $$178.38M
Sell $$2.40B
Ratio1:13.43
% Change vs. Prior
Ratio -71.7%Value +11.2%
Computer Hardware
Buys0
Sells1953
Buy $$0.00
Sell $$2.34B
RatioAll Sells
% Change vs. Prior
Ratio -100.0%Value +29.9%
Specialty Retail
Buys58
Sells877
Buy $$37.90M
Sell $$2.26B
Ratio1:59.57
% Change vs. Prior
Ratio -81.7%Value +20.9%
Semiconductors
Buys125
Sells1417
Buy $$12.65M
Sell $$2.20B
Ratio1:173.91
% Change vs. Prior
Ratio +339.1%Value -14.4%
Oil & Gas Exploration & Production
Buys133
Sells116
Buy $$23.98M
Sell $$2.18B
Ratio1:90.71
% Change vs. Prior
Ratio -12.0%Value -37.1%
Medical - Healthcare Information Services
Buys11
Sells375
Buy $$637.20K
Sell $$2.13B
Ratio1:3346.42
% Change vs. Prior
Ratio -98.6%Value +18.0%
Leisure
Buys6
Sells118
Buy $$7.13M
Sell $$1.34B
Ratio1:187.24
Information Technology Services
Buys25
Sells199
Buy $$4.93M
Sell $$1.27B
Ratio1:257.52
Furnishings, Fixtures & Appliances
Buys16
Sells112
Buy $$839.71K
Sell $$1.20B
Ratio1:1424.03
Beverages - Non-Alcoholic
Buys12
Sells36
Buy $$2.32M
Sell $$1.18B
Ratio1:507.66
Banks - Regional
Buys425
Sells1131
Buy $$32.68M
Sell $$1.13B
Ratio1:34.58
Apparel - Footwear & Accessories
Buys3
Sells48
Buy $$229.14K
Sell $$1.12B
Ratio1:4888.03
Transactions (26742)
Velocity Financial, Inc. (VEL)
Kelly Roland Thomas — Chief Legal Officer and GC
Shares
1,600
Price
$18.00
Total Value
$28.80K
Shares Held After
95,794
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
320
Price
$522.39
Total Value
$167.17K
Shares Held After
45,172
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,308
Price
$521.50
Total Value
$682.12K
Shares Held After
45,492
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
360
Price
$518.82
Total Value
$186.78K
Shares Held After
46,800
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
780
Price
$517.94
Total Value
$403.99K
Shares Held After
47,160
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,617
Price
$516.93
Total Value
$835.87K
Shares Held After
47,940
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,360
Price
$515.93
Total Value
$701.67K
Shares Held After
49,557
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,795
Price
$514.82
Total Value
$924.11K
Shares Held After
50,917
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
760
Price
$512.92
Total Value
$389.82K
Shares Held After
52,712
% of Holdings
1.4%
NETFLIX INC (NFLX)
Peters Gregory K — Director
Shares
27,312
Price
$73.54
Total Value
$2.01M
Shares Held After
120,931
% of Holdings
18.4%
Velocity Financial, Inc. (VEL)
Szczepaniak Mark R — Chief Financial Officer
Shares
400
Price
$18.00
Total Value
$7.20K
Shares Held After
66,400
% of Holdings
0.6%
FARMERS NATIONAL BANC CORP /OH/ (FMNB)
Wenick Mark J — SEVP/Chief Wealth Mgt Officer
Shares
5,000
Price
$15.97
Total Value
$79.85K
Shares Held After
32,020
% of Holdings
13.5%
SILICOM LTD. (SILC)
Gilad Eran — CFO
Shares
6,975
Price
$44.44
Total Value
$309.97K
Shares Held After
0
% of Holdings
100.0%
SILICOM LTD. (SILC)
Gilad Eran — CFO
Shares
25
Price
$46.56
Total Value
$1.16K
Shares Held After
6,975
% of Holdings
0.4%
Infleqtion, Inc. (INFQ)
MAVERICK CAPITAL LTD — Director
Shares
1,324
Price
$10.88
Total Value
$14.41K
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
76,418
Price
$21.04
Total Value
$1.61M
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
6,763
Price
$21.61
Total Value
$146.15K
Shares Held After
55,611
% of Holdings
10.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
100
Price
$21.99
Total Value
$2.20K
Shares Held After
62,374
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,163
Price
$22.19
Total Value
$25.81K
Shares Held After
62,474
% of Holdings
1.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
700
Price
$22.07
Total Value
$15.45K
Shares Held After
63,637
% of Holdings
1.1%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
64,337
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
443
Price
$21.78
Total Value
$9.65K
Shares Held After
64,537
% of Holdings
0.7%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
300
Price
$20.84
Total Value
$6.25K
Shares Held After
64,980
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,040
Price
$22.05
Total Value
$22.93K
Shares Held After
65,280
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,180
Price
$21.84
Total Value
$25.77K
Shares Held After
66,320
% of Holdings
1.7%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
400
Price
$22.02
Total Value
$8.81K
Shares Held After
67,500
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
6,970
Price
$22.03
Total Value
$153.55K
Shares Held After
67,900
% of Holdings
9.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
672
Price
$22.02
Total Value
$14.80K
Shares Held After
74,870
% of Holdings
0.9%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
753
Price
$21.97
Total Value
$16.54K
Shares Held After
75,542
% of Holdings
1.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
100
Price
$22.11
Total Value
$2.21K
Shares Held After
76,295
% of Holdings
0.1%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
480
Price
$21.55
Total Value
$10.34K
Shares Held After
76,395
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.10
Total Value
$4.42K
Shares Held After
76,875
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
3,402
Price
$22.02
Total Value
$74.91K
Shares Held After
77,075
% of Holdings
4.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,556
Price
$22.06
Total Value
$34.33K
Shares Held After
80,477
% of Holdings
1.9%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
76,418
Price
$21.04
Total Value
$1.61M
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
82,033
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
6,763
Price
$21.61
Total Value
$146.15K
Shares Held After
55,611
% of Holdings
10.8%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
100
Price
$21.99
Total Value
$2.20K
Shares Held After
62,374
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,332
Price
$22.03
Total Value
$29.34K
Shares Held After
82,233
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,163
Price
$22.19
Total Value
$25.81K
Shares Held After
62,474
% of Holdings
1.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
447
Price
$21.87
Total Value
$9.78K
Shares Held After
83,565
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
700
Price
$22.07
Total Value
$15.45K
Shares Held After
63,637
% of Holdings
1.1%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
64,337
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
988
Price
$22.03
Total Value
$21.77K
Shares Held After
84,012
% of Holdings
1.2%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
443
Price
$21.78
Total Value
$9.65K
Shares Held After
64,537
% of Holdings
0.7%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
300
Price
$20.84
Total Value
$6.25K
Shares Held After
64,980
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,040
Price
$22.05
Total Value
$22.93K
Shares Held After
65,280
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,180
Price
$21.84
Total Value
$25.77K
Shares Held After
66,320
% of Holdings
1.7%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
400
Price
$22.02
Total Value
$8.81K
Shares Held After
67,500
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
6,970
Price
$22.03
Total Value
$153.55K
Shares Held After
67,900
% of Holdings
9.3%
Showing 2301–2350 of 26742 transactions (page 47 of 535)